A citation-based method for searching scientific literature

Candi L Lasarge, Steve C Danzer. Front Mol Neurosci 2014
Times Cited: 99







List of co-cited articles
859 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Ling-Hui Zeng, Lin Xu, David H Gutmann, Michael Wong. Ann Neurol 2008
420
19

Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy.
Raymund Y K Pun, Isaiah J Rolle, Candi L Lasarge, Bethany E Hosford, Jules M Rosen, Juli D Uhl, Sarah N Schmeltzer, Christian Faulkner, Stefanie L Bronson, Brian L Murphy,[...]. Neuron 2012
173
18


mTOR signaling in growth control and disease.
Mathieu Laplante, David M Sabatini. Cell 2012
17

De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.
Jeong Ho Lee, My Huynh, Jennifer L Silhavy, Sangwoo Kim, Tracy Dixon-Salazar, Andrew Heiberg, Eric Scott, Vineet Bafna, Kiley J Hill, Adrienne Collazo,[...]. Nat Genet 2012
412
16

The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.
Ingmar Blümcke, Maria Thom, Eleonora Aronica, Dawna D Armstrong, Harry V Vinters, Andre Palmini, Thomas S Jacques, Giuliano Avanzini, A James Barkovich, Giorgio Battaglia,[...]. Epilepsia 2011
994
16

Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.
Darcy A Krueger, Angus A Wilfong, Katherine Holland-Bouley, Anne E Anderson, Karen Agricola, Cindy Tudor, Maxwell Mays, Christina M Lopez, Mi-Ok Kim, David Neal Franz. Ann Neurol 2013
242
16

Mutations in DEPDC5 cause familial focal epilepsy with variable foci.
Leanne M Dibbens, Boukje de Vries, Simona Donatello, Sarah E Heron, Bree L Hodgson, Satyan Chintawar, Douglas E Crompton, James N Hughes, Susannah T Bellows, Karl Martin Klein,[...]. Nat Genet 2013
193
15

Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2.
Sohail F Tavazoie, Veronica A Alvarez, Dennis A Ridenour, David J Kwiatkowski, Bernardo L Sabatini. Nat Neurosci 2005
351
15

Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
Jae Seok Lim, Woo-il Kim, Hoon-Chul Kang, Se Hoon Kim, Ah Hyung Park, Eun Kyung Park, Young-Wook Cho, Sangwoo Kim, Ho Min Kim, Jeong A Kim,[...]. Nat Med 2015
252
15

Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy.
Xiaoxing Huang, Hailong Zhang, Jun Yang, Jingfan Wu, John McMahon, Yufan Lin, Zhonglian Cao, Michael Gruenthal, Yunfei Huang. Neurobiol Dis 2010
181
14

mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
Marianna Baybis, Jia Yu, Allana Lee, Jeff A Golden, Howard Weiner, Guy McKhann, Eleonora Aronica, Peter B Crino. Ann Neurol 2004
193
14

Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.
Ingrid E Scheffer, Sarah E Heron, Brigid M Regan, Simone Mandelstam, Douglas E Crompton, Bree L Hodgson, Laura Licchetta, Federica Provini, Francesca Bisulli, Lata Vadlamudi,[...]. Ann Neurol 2014
132
14

Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.
Stéphanie Baulac, Saeko Ishida, Elise Marsan, Catherine Miquel, Arnaud Biraben, Dang Khoa Nguyen, Doug Nordli, Patrick Cossette, Sylvie Nguyen, Virginie Lambrecq,[...]. Ann Neurol 2015
147
14

A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1.
Liron Bar-Peled, Lynne Chantranupong, Andrew D Cherniack, Walter W Chen, Kathleen A Ottina, Brian C Grabiner, Eric D Spear, Scott L Carter, Matthew Meyerson, David M Sabatini. Science 2013
572
13

Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder.
Whitney E Parker, Ksenia A Orlova, William H Parker, Jacqueline F Birnbaum, Vera P Krymskaya, Dmitry A Goncharov, Marianna Baybis, Jelte Helfferich, Kei Okochi, Kevin A Strauss,[...]. Sci Transl Med 2013
75
16

PI3K-Akt signaling activates mTOR-mediated epileptogenesis in organotypic hippocampal culture model of post-traumatic epilepsy.
Yevgeny Berdichevsky, Alexandra M Dryer, Yero Saponjian, Mark M Mahoney, Corrin A Pimentel, Corrina A Lucini, Marija Usenovic, Kevin J Staley. J Neurosci 2013
59
20

Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis.
Helen S Bateup, Caroline A Johnson, Cassandra L Denefrio, Jessica L Saulnier, Karl Kornacker, Bernardo L Sabatini. Neuron 2013
205
12

The neurology of mTOR.
Jonathan O Lipton, Mustafa Sahin. Neuron 2014
364
12

mTOR signaling: at the crossroads of plasticity, memory and disease.
Charles A Hoeffer, Eric Klann. Trends Neurosci 2010
729
11


Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
David Neal Franz, Elena Belousova, Steven Sparagana, E Martina Bebin, Michael Frost, Rachel Kuperman, Olaf Witt, Michael H Kohrman, J Robert Flamini, Joyce Y Wu,[...]. Lancet 2013
486
11

The natural history of epilepsy in tuberous sclerosis complex.
Catherine J Chu-Shore, Philippe Major, Susana Camposano, David Muzykewicz, Elizabeth A Thiele. Epilepsia 2010
344
11

Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.
Darcy A Krueger, Marguerite M Care, Katherine Holland, Karen Agricola, Cynthia Tudor, Prajakta Mangeshkar, Kimberly A Wilson, Anna Byars, Tarek Sahmoud, David Neal Franz. N Engl J Med 2010
644
11

Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.
Alissa M D'Gama, Ying Geng, Javier A Couto, Beth Martin, Evan A Boyle, Christopher M LaCoursiere, Amer Hossain, Nicole E Hatem, Brenda J Barry, David J Kwiatkowski,[...]. Ann Neurol 2015
156
11

The tuberous sclerosis complex.
Peter B Crino, Katherine L Nathanson, Elizabeth Petri Henske. N Engl J Med 2006
10

Role of the mTOR signaling pathway in epilepsy.
Xiang-Fei Meng, Jin-Tai Yu, Jing-Hui Song, Song Chi, Lan Tan. J Neurol Sci 2013
70
14

STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice.
Ksenia A Orlova, Whitney E Parker, Gregory G Heuer, Victoria Tsai, Jason Yoon, Marianna Baybis, Robert S Fenning, Kevin Strauss, Peter B Crino. J Clin Invest 2010
84
11

DEPDC5 mutations in genetic focal epilepsies of childhood.
Dennis Lal, Eva M Reinthaler, Julian Schubert, Hiltrud Muhle, Erik Riesch, Gerhard Kluger, Kamel Jabbari, Amit Kawalia, Christine Bäumel, Hans Holthausen,[...]. Ann Neurol 2014
74
13

Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice.
Jing Zhou, Jacqueline Blundell, Shiori Ogawa, Chang-Hyuk Kwon, Wei Zhang, Christopher Sinton, Craig M Powell, Luis F Parada. J Neurosci 2009
289
10

Pten regulates neuronal arborization and social interaction in mice.
Chang-Hyuk Kwon, Bryan W Luikart, Craig M Powell, Jing Zhou, Sharon A Matheny, Wei Zhang, Yanjiao Li, Suzanne J Baker, Luis F Parada. Neuron 2006
667
10

The tuberous sclerosis complex.
Ksenia A Orlova, Peter B Crino. Ann N Y Acad Sci 2010
263
10

Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia.
M Cecilia Ljungberg, C Nicole Sunnen, Joaquin N Lugo, Anne E Anderson, Gabriella D'Arcangelo. Dis Model Mech 2009
125
10

Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.
Lynsey Meikle, Kristen Pollizzi, Anna Egnor, Ioannis Kramvis, Heidi Lane, Mustafa Sahin, David J Kwiatkowski. J Neurosci 2008
347
10

Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
Jacqueline A French, John A Lawson, Zuhal Yapici, Hiroko Ikeda, Tilman Polster, Rima Nabbout, Paolo Curatolo, Petrus J de Vries, Dennis J Dlugos, Noah Berkowitz,[...]. Lancet 2016
302
10


Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
Michael Cardamone, Danny Flanagan, David Mowat, Sean E Kennedy, Maya Chopra, John A Lawson. J Pediatr 2014
86
10

DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy.
Fabienne Picard, Periklis Makrythanasis, Vincent Navarro, Saeko Ishida, Julitta de Bellescize, Dorothée Ville, Sarah Weckhuysen, Erwin Fosselle, Arvid Suls, Peter De Jonghe,[...]. Neurology 2014
77
11

A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus.
Shao Jun Tang, Gerald Reis, Hyejin Kang, Anne-Claude Gingras, Nahum Sonenberg, Erin M Schuman. Proc Natl Acad Sci U S A 2002
548
9

Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease.
C H Kwon, X Zhu, J Zhang, L L Knoop, R Tharp, R J Smeyne, C G Eberhart, P C Burger, S J Baker. Nat Genet 2001
339
9


Mutations of DEPDC5 cause autosomal dominant focal epilepsies.
Saeko Ishida, Fabienne Picard, Gabrielle Rudolf, Eric Noé, Guillaume Achaz, Pierre Thomas, Pierre Genton, Emeline Mundwiller, Markus Wolff, Christian Marescaux,[...]. Nat Genet 2013
143
9

The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway.
Delia M Talos, Hongyu Sun, Xiangping Zhou, Erin C Fitzgerald, Michele C Jackson, Peter M Klein, Victor J Lan, Annelise Joseph, Frances E Jensen. PLoS One 2012
127
9

TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice.
Elisabeth Abs, Susanna M I Goorden, Jadwiga Schreiber, Iris E Overwater, Marianne Hoogeveen-Westerveld, Caroline F Bruinsma, Elvedin Aganović, Nils Z Borgesius, Mark Nellist, Ype Elgersma. Ann Neurol 2013
55
16

Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies.
Joan Liu, Cheryl Reeves, Zuzanna Michalak, Antonietta Coppola, Beate Diehl, Sanjay M Sisodiya, Maria Thom. Acta Neuropathol Commun 2014
66
13

Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia.
M Cecilia Ljungberg, Meenakshi B Bhattacharjee, Yaojuan Lu, Dawna L Armstrong, Daniel Yoshor, John W Swann, Michael Sheldon, Gabriella D'Arcangelo. Ann Neurol 2006
120
9

Fetal brain mTOR signaling activation in tuberous sclerosis complex.
Victoria Tsai, Whitney E Parker, Ksenia A Orlova, Marianna Baybis, Anthony W S Chi, Benjamin D Berg, Jacqueline F Birnbaum, Jacqueline Estevez, Kei Okochi, Harvey B Sarnat,[...]. Cereb Cortex 2014
75
12

Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice.
David M Feliciano, Tiffany Su, Jean Lopez, Jean-Claude Platel, Angélique Bordey. J Clin Invest 2011
109
9

Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.
Dan Ehninger, Sangyeul Han, Carrie Shilyansky, Yu Zhou, Weidong Li, David J Kwiatkowski, Vijaya Ramesh, Alcino J Silva. Nat Med 2008
581
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.